The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Butorphanol Market Research Report 2024

Global Butorphanol Market Research Report 2024

Publishing Date : Feb, 2021

License Type :
 

Report Code : 1582155

No of Pages : 116

Synopsis
Butorphanol is a morphinan-type synthetic agonist–antagonist opioid analgesic developed by Bristol-Myers. Butorphanol is available as the tartrate salt in injectable, tablet, and intranasal spray formulations. The tablet form is only used in dogs, cats and horses due to low bioavailability in humans.

The global Butorphanol market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Butorphanol volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Butorphanol market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Butorphanol Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Spray
Injection
Tablet

Segment by Application
Human
Veterinary

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Hikma Pharmaceuticals
Athanas Enterprise Private Limited
Pfizer
Apothecon Pharmaceuticals
Mylan
Novex Pharma
Bristol Myers Squibb
Sanochemia Pharmazeutika
Selectavet
Richter Pharma Ag
Troy Laboratories Nz
Animedica
Boehringer Ingelheim Santé Animale
Ausrichter
Zoetis
Dechra Pharmaceuticals
Faunapharma
Merck KGaA
Index
1 Butorphanol Market Overview
1.1 Product Overview and Scope of Butorphanol
1.2 Butorphanol Segment by Type
1.2.1 Global Butorphanol Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Spray
1.2.3 Injection
1.2.4 Tablet
1.3 Butorphanol Segment by Application
1.3.1 Butorphanol Sales Comparison by Application: (2021-2027)
1.3.2 Human
1.3.3 Veterinary
1.4 Global Butorphanol Market Size Estimates and Forecasts
1.4.1 Global Butorphanol Revenue 2016-2027
1.4.2 Global Butorphanol Sales 2016-2027
1.4.3 Butorphanol Market Size by Region: 2016 Versus 2021 Versus 2027

2 Butorphanol Market Competition by Manufacturers
2.1 Global Butorphanol Sales Market Share by Manufacturers (2016-2021)
2.2 Global Butorphanol Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Butorphanol Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Butorphanol Manufacturing Sites, Area Served, Product Type
2.5 Butorphanol Market Competitive Situation and Trends
2.5.1 Butorphanol Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Butorphanol Players Market Share by Revenue
2.5.3 Global Butorphanol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Butorphanol Retrospective Market Scenario by Region
3.1 Global Butorphanol Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Butorphanol Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Butorphanol Market Facts & Figures by Country
3.3.1 North America Butorphanol Sales by Country
3.3.2 North America Butorphanol Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Butorphanol Market Facts & Figures by Country
3.4.1 Europe Butorphanol Sales by Country
3.4.2 Europe Butorphanol Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Butorphanol Market Facts & Figures by Region
3.5.1 Asia Pacific Butorphanol Sales by Region
3.5.2 Asia Pacific Butorphanol Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Butorphanol Market Facts & Figures by Country
3.6.1 Latin America Butorphanol Sales by Country
3.6.2 Latin America Butorphanol Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Butorphanol Market Facts & Figures by Country
3.7.1 Middle East and Africa Butorphanol Sales by Country
3.7.2 Middle East and Africa Butorphanol Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Butorphanol Historic Market Analysis by Type
4.1 Global Butorphanol Sales Market Share by Type (2016-2021)
4.2 Global Butorphanol Revenue Market Share by Type (2016-2021)
4.3 Global Butorphanol Price by Type (2016-2021)

5 Global Butorphanol Historic Market Analysis by Application
5.1 Global Butorphanol Sales Market Share by Application (2016-2021)
5.2 Global Butorphanol Revenue Market Share by Application (2016-2021)
5.3 Global Butorphanol Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Hikma Pharmaceuticals
6.1.1 Hikma Pharmaceuticals Corporation Information
6.1.2 Hikma Pharmaceuticals Description and Business Overview
6.1.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Hikma Pharmaceuticals Product Portfolio
6.1.5 Hikma Pharmaceuticals Recent Developments/Updates
6.2 Athanas Enterprise Private Limited
6.2.1 Athanas Enterprise Private Limited Corporation Information
6.2.2 Athanas Enterprise Private Limited Description and Business Overview
6.2.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Athanas Enterprise Private Limited Product Portfolio
6.2.5 Athanas Enterprise Private Limited Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Apothecon Pharmaceuticals
6.4.1 Apothecon Pharmaceuticals Corporation Information
6.4.2 Apothecon Pharmaceuticals Description and Business Overview
6.4.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Apothecon Pharmaceuticals Product Portfolio
6.4.5 Apothecon Pharmaceuticals Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Mylan Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Novex Pharma
6.6.1 Novex Pharma Corporation Information
6.6.2 Novex Pharma Description and Business Overview
6.6.3 Novex Pharma Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novex Pharma Product Portfolio
6.6.5 Novex Pharma Recent Developments/Updates
6.7 Bristol Myers Squibb
6.6.1 Bristol Myers Squibb Corporation Information
6.6.2 Bristol Myers Squibb Description and Business Overview
6.6.3 Bristol Myers Squibb Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bristol Myers Squibb Product Portfolio
6.7.5 Bristol Myers Squibb Recent Developments/Updates
6.8 Sanochemia Pharmazeutika
6.8.1 Sanochemia Pharmazeutika Corporation Information
6.8.2 Sanochemia Pharmazeutika Description and Business Overview
6.8.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sanochemia Pharmazeutika Product Portfolio
6.8.5 Sanochemia Pharmazeutika Recent Developments/Updates
6.9 Selectavet
6.9.1 Selectavet Corporation Information
6.9.2 Selectavet Description and Business Overview
6.9.3 Selectavet Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Selectavet Product Portfolio
6.9.5 Selectavet Recent Developments/Updates
6.10 Richter Pharma Ag
6.10.1 Richter Pharma Ag Corporation Information
6.10.2 Richter Pharma Ag Description and Business Overview
6.10.3 Richter Pharma Ag Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Richter Pharma Ag Product Portfolio
6.10.5 Richter Pharma Ag Recent Developments/Updates
6.11 Troy Laboratories Nz
6.11.1 Troy Laboratories Nz Corporation Information
6.11.2 Troy Laboratories Nz Butorphanol Description and Business Overview
6.11.3 Troy Laboratories Nz Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Troy Laboratories Nz Product Portfolio
6.11.5 Troy Laboratories Nz Recent Developments/Updates
6.12 Animedica
6.12.1 Animedica Corporation Information
6.12.2 Animedica Butorphanol Description and Business Overview
6.12.3 Animedica Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Animedica Product Portfolio
6.12.5 Animedica Recent Developments/Updates
6.13 Boehringer Ingelheim Santé Animale
6.13.1 Boehringer Ingelheim Santé Animale Corporation Information
6.13.2 Boehringer Ingelheim Santé Animale Butorphanol Description and Business Overview
6.13.3 Boehringer Ingelheim Santé Animale Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Boehringer Ingelheim Santé Animale Product Portfolio
6.13.5 Boehringer Ingelheim Santé Animale Recent Developments/Updates
6.14 Ausrichter
6.14.1 Ausrichter Corporation Information
6.14.2 Ausrichter Butorphanol Description and Business Overview
6.14.3 Ausrichter Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Ausrichter Product Portfolio
6.14.5 Ausrichter Recent Developments/Updates
6.15 Zoetis
6.15.1 Zoetis Corporation Information
6.15.2 Zoetis Butorphanol Description and Business Overview
6.15.3 Zoetis Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Zoetis Product Portfolio
6.15.5 Zoetis Recent Developments/Updates
6.16 Dechra Pharmaceuticals
6.16.1 Dechra Pharmaceuticals Corporation Information
6.16.2 Dechra Pharmaceuticals Butorphanol Description and Business Overview
6.16.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Dechra Pharmaceuticals Product Portfolio
6.16.5 Dechra Pharmaceuticals Recent Developments/Updates
6.17 Faunapharma
6.17.1 Faunapharma Corporation Information
6.17.2 Faunapharma Butorphanol Description and Business Overview
6.17.3 Faunapharma Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Faunapharma Product Portfolio
6.17.5 Faunapharma Recent Developments/Updates
6.18 Merck KGaA
6.18.1 Merck KGaA Corporation Information
6.18.2 Merck KGaA Butorphanol Description and Business Overview
6.18.3 Merck KGaA Butorphanol Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Merck KGaA Product Portfolio
6.18.5 Merck KGaA Recent Developments/Updates

7 Butorphanol Manufacturing Cost Analysis
7.1 Butorphanol Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Butorphanol
7.4 Butorphanol Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Butorphanol Distributors List
8.3 Butorphanol Customers

9 Butorphanol Market Dynamics
9.1 Butorphanol Industry Trends
9.2 Butorphanol Growth Drivers
9.3 Butorphanol Market Challenges
9.4 Butorphanol Market Restraints

10 Global Market Forecast
10.1 Butorphanol Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Butorphanol by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Butorphanol by Type (2022-2027)
10.2 Butorphanol Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Butorphanol by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Butorphanol by Application (2022-2027)
10.3 Butorphanol Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Butorphanol by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Butorphanol by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Butorphanol Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Butorphanol Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Butorphanol Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Butorphanol Covered in This Study
Table 5. Global Butorphanol Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Butorphanol Sales Share by Manufacturers (2016-2021)
Table 7. Global Butorphanol Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Butorphanol Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Butorphanol Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Butorphanol Manufacturing Sites and Area Served
Table 11. Manufacturers Butorphanol Product Type
Table 12. Global Butorphanol Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Butorphanol by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Butorphanol as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Butorphanol Sales by Region (2016-2021) & (K Units)
Table 16. Global Butorphanol Sales Market Share by Region (2016-2021)
Table 17. Global Butorphanol Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Butorphanol Sales by Country (2016-2021) & (K Units)
Table 19. North America Butorphanol Sales Market Share by Country (2016-2021)
Table 20. North America Butorphanol Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Butorphanol Revenue Market Share by Country (2016-2021)
Table 22. Europe Butorphanol Sales by Country (2016-2021) & (K Units)
Table 23. Europe Butorphanol Sales Market Share by Country (2016-2021)
Table 24. Europe Butorphanol Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Butorphanol Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Butorphanol Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Butorphanol Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Butorphanol Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Butorphanol Revenue Market Share by Region (2016-2021)
Table 30. Latin America Butorphanol Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Butorphanol Sales Market Share by Country (2016-2021)
Table 32. Latin America Butorphanol Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Butorphanol Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Butorphanol Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Butorphanol Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Butorphanol Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Butorphanol Revenue Market Share by Country (2016-2021)
Table 38. Global Butorphanol Sales (K Units) by Type (2016-2021)
Table 39. Global Butorphanol Sales Market Share by Type (2016-2021)
Table 40. Global Butorphanol Revenue (Million US$) by Type (2016-2021)
Table 41. Global Butorphanol Revenue Share by Type (2016-2021)
Table 42. Global Butorphanol Price (US$/Unit) by Type (2016-2021)
Table 43. Global Butorphanol Sales (K Units) by Application (2016-2021)
Table 44. Global Butorphanol Sales Market Share by Application (2016-2021)
Table 45. Global Butorphanol Revenue (Million US$) by Application (2016-2021)
Table 46. Global Butorphanol Revenue Share by Application (2016-2021)
Table 47. Global Butorphanol Price (US$/Unit) by Application (2016-2021)
Table 48. Hikma Pharmaceuticals Corporation Information
Table 49. Hikma Pharmaceuticals Description and Business Overview
Table 50. Hikma Pharmaceuticals Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Hikma Pharmaceuticals Butorphanol Product
Table 52. Hikma Pharmaceuticals Recent Developments/Updates
Table 53. Athanas Enterprise Private Limited Corporation Information
Table 54. Athanas Enterprise Private Limited Description and Business Overview
Table 55. Athanas Enterprise Private Limited Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Athanas Enterprise Private Limited Butorphanol Product
Table 57. Athanas Enterprise Private Limited Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer Butorphanol Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Apothecon Pharmaceuticals Corporation Information
Table 64. Apothecon Pharmaceuticals Description and Business Overview
Table 65. Apothecon Pharmaceuticals Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Apothecon Pharmaceuticals Butorphanol Product
Table 67. Apothecon Pharmaceuticals Recent Developments/Updates
Table 68. Mylan Corporation Information
Table 69. Mylan Description and Business Overview
Table 70. Mylan Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Mylan Butorphanol Product
Table 72. Mylan Recent Developments/Updates
Table 73. Novex Pharma Corporation Information
Table 74. Novex Pharma Description and Business Overview
Table 75. Novex Pharma Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Novex Pharma Butorphanol Product
Table 77. Novex Pharma Recent Developments/Updates
Table 78. Bristol Myers Squibb Corporation Information
Table 79. Bristol Myers Squibb Description and Business Overview
Table 80. Bristol Myers Squibb Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Bristol Myers Squibb Butorphanol Product
Table 82. Bristol Myers Squibb Recent Developments/Updates
Table 83. Sanochemia Pharmazeutika Corporation Information
Table 84. Sanochemia Pharmazeutika Description and Business Overview
Table 85. Sanochemia Pharmazeutika Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Sanochemia Pharmazeutika Butorphanol Product
Table 87. Sanochemia Pharmazeutika Recent Developments/Updates
Table 88. Selectavet Corporation Information
Table 89. Selectavet Description and Business Overview
Table 90. Selectavet Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Selectavet Butorphanol Product
Table 92. Selectavet Recent Developments/Updates
Table 93. Richter Pharma Ag Corporation Information
Table 94. Richter Pharma Ag Description and Business Overview
Table 95. Richter Pharma Ag Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Richter Pharma Ag Butorphanol Product
Table 97. Richter Pharma Ag Recent Developments/Updates
Table 98. Troy Laboratories Nz Corporation Information
Table 99. Troy Laboratories Nz Description and Business Overview
Table 100. Troy Laboratories Nz Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Troy Laboratories Nz Butorphanol Product
Table 102. Troy Laboratories Nz Recent Developments/Updates
Table 103. Animedica Corporation Information
Table 104. Animedica Description and Business Overview
Table 105. Animedica Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Animedica Butorphanol Product
Table 107. Animedica Recent Developments/Updates
Table 108. Boehringer Ingelheim Santé Animale Corporation Information
Table 109. Boehringer Ingelheim Santé Animale Description and Business Overview
Table 110. Boehringer Ingelheim Santé Animale Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Boehringer Ingelheim Santé Animale Butorphanol Product
Table 112. Boehringer Ingelheim Santé Animale Recent Developments/Updates
Table 113. Ausrichter Corporation Information
Table 114. Ausrichter Description and Business Overview
Table 115. Ausrichter Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Ausrichter Butorphanol Product
Table 117. Ausrichter Recent Developments/Updates
Table 118. Zoetis Corporation Information
Table 119. Zoetis Description and Business Overview
Table 120. Zoetis Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Zoetis Butorphanol Product
Table 122. Zoetis Recent Developments/Updates
Table 123. Dechra Pharmaceuticals Corporation Information
Table 124. Dechra Pharmaceuticals Description and Business Overview
Table 125. Dechra Pharmaceuticals Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Dechra Pharmaceuticals Butorphanol Product
Table 127. Dechra Pharmaceuticals Recent Developments/Updates
Table 128. Faunapharma Corporation Information
Table 129. Faunapharma Description and Business Overview
Table 130. Faunapharma Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Faunapharma Butorphanol Product
Table 132. Faunapharma Recent Developments/Updates
Table 133. Merck KGaA Corporation Information
Table 134. Merck KGaA Description and Business Overview
Table 135. Merck KGaA Butorphanol Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Merck KGaA Butorphanol Product
Table 137. Merck KGaA Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Butorphanol Distributors List
Table 141. Butorphanol Customers List
Table 142. Butorphanol Market Trends
Table 143. Butorphanol Growth Drivers
Table 144. Butorphanol Market Restraints
Table 145. Global Butorphanol Sales Forecast by Type (2022-2027) & (K Units)
Table 146. Global Butorphanol Sales Market Share Forecast by Type (2022-2027)
Table 147. Global Butorphanol Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 148. Global Butorphanol Revenue Market Share Forecast by Type (2022-2027)
Table 149. Global Butorphanol Sales Forecast by Application (2022-2027) & (K Units)
Table 150. Global Butorphanol Sales Market Share Forecast by Application (2022-2027)
Table 151. Global Butorphanol Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 152. Global Butorphanol Revenue Market Share Forecast by Application (2022-2027)
Table 153. Global Butorphanol Sales Forecast by Region (2022-2027) & (K Units)
Table 154. Global Butorphanol Sales Market Share Forecast by Region (2022-2027)
Table 155. Global Butorphanol Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 156. Global Butorphanol Revenue Market Share Forecast by Region (2022-2027)
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Butorphanol
Figure 2. Global Butorphanol Market Share by Type in 2020 & 2027
Figure 3. Spray Product Picture
Figure 4. Injection Product Picture
Figure 5. Tablet Product Picture
Figure 6. Global Butorphanol Market Share by Application in 2020 & 2027
Figure 7. Human
Figure 8. Veterinary
Figure 9. Global Butorphanol Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Butorphanol Market Size 2016-2027 (US$ Million)
Figure 11. Global Butorphanol Sales 2016-2027 (K Units)
Figure 12. Global Butorphanol Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Butorphanol Sales Share by Manufacturers in 2020
Figure 14. Global Butorphanol Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Butorphanol Players: Market Share by Revenue in 2020
Figure 16. Butorphanol Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Butorphanol Sales Market Share by Region (2016-2021)
Figure 18. Global Butorphanol Sales Market Share by Region in 2020
Figure 19. Global Butorphanol Revenue Market Share by Region (2016-2021)
Figure 20. Global Butorphanol Revenue Market Share by Region in 2020
Figure 21. U.S. Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Butorphanol Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Butorphanol by Type (2016-2021)
Figure 46. Sales Market Share of Butorphanol by Application (2016-2021)
Figure 47. Sales Market Share of Butorphanol by Application in 2020
Figure 48. Revenue Share of Butorphanol by Application (2016-2021)
Figure 49. Revenue Share of Butorphanol by Application in 2020
Figure 50. Manufacturing Cost Structure of Butorphanol
Figure 51. Manufacturing Process Analysis of Butorphanol
Figure 52. Butorphanol Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’